Diabetic nephropathy: the proteinuria hypothesis.
OBJECTIVE
Proteinuria, nearly a universal finding in progressive kidney disease, has been the subject of frequent recent analyses in the renal literature. Proteinuria is a hallmark of diabetic nephropathy: microalbuminuria is the principal early predictor for progression of diabetic glomerulopathy, and proteinuria may be viewed as a measure of the severity and promoter of progression of nephropathy.


METHODS
This article critically reviews for the first time the full scope of diabetic proteinuria--complex molecular mechanisms, natural history, and analysis of treatment trials--in order to address the validity of 'the proteinuria hypothesis', i.e., that diabetic proteinuria is a modifiable determinant of renal progression. This hypothesis is analyzed in detail, including recent studies on the primary therapy of diabetic nephropathy, renin-angiotensin blockade.


RESULTS
As fully developed, this hypothesis consists of three postulates: that higher amounts of proteinuria predict progressive loss of function, that proteinuria reduction correlates with slowing progression, and that proteinuria is a surrogate endpoint for clinical trials. The latter postulate has not before been adequately linked to growing information about the first two postulates as they apply to diabetic kidney disease.


CONCLUSIONS
While diabetic nephropathy is a disease model for the potential use of proteinuria as a surrogate marker for renal progression, this shift in perspective will require prospective data from additional clinical trials, particularly of non-renin-angiotensin blocking drugs, to be complete.
Williams
Mark E
ME
Joslin Diabetes Center, Harvard Medical School, Boston, Mass., USA. mark.williams@joslin.harvard.edu
D003928:Diabetic Nephropathies / Q000150:complications / Q000503:physiopathology* / Q000652:urine; D018450:Disease Progression; D006801:Humans; D011237:Predictive Value of Tests; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*